Enterohemorrhagic and other Shigatoxin-producing Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 165

Oliveira, M.G., Brito, J.R., Gomes, T.A., et al., 2008. Diversity of virulence proiles of Shiga
toxin-producing Escherichia coli serotypes in food-producing animals in Brazil. Int. J. Food
Microbiol. 127 (1-2), 139-146 .
Ooka, T., Vieira, M.A., Ogura, Y., et al., 2007. Characterization of tccP2 carried by atypical
enteropathogenic Escherichia coli . FEMS Microbiol. Lett. 271 (1), 126-135 .
Oporto, B., Esteban, J.I., Aduriz, G., et al., 2008. Escherichia coli O157:H7 and non-O157 Shiga
toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain. Zoonoses
Public Health 55 (2), 73-81 .
Orth, D., Grif, K., Zimmerhackl, L.B., et al., 2008. Prevention and treatment of enterohemorrhagic
Escherichia coli infections in humans. Expert Rev. Anti. Infect. Ther. 6 (1), 101-108 .
Orth, D., Khan, A.B., Naim, A., et al., 2009. Shiga toxin activates complement and binds factor H:
evidence for an active role of complement in hemolytic uremic syndrome. J. Immunol. 182
(10), 6394-6400 .
Ostroff, S.M., Kobayashi, J.M., Lewis, J.H., 1989. Infections with Escherichia coli O157:H7 in
Washington State. The irst year of statewide disease surveillance. JAMA 262 (3), 355-359 .
Oswald, E., Schmidt, H., Morabito, S., et al., 2000. Typing of intimin genes in human and animal
enterohemorrhagic and enteropathogenic Escherichia coli : characterization of a new intimin
variant. Infect. Immun. 68 (1), 64-71 .
Palermo, M., Alves-Rosa, F., Rubel, C., et al., 2000. Pretreatment of mice with lipopolysaccharide
(LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin. Exp.
Immunol. 119 (1), 77-83 .
Papatheodorou, P., Domanska, G., Oxle, M., et al., 2006. The enteropathogenic Escherichia coli
(EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and
alters organelle morphology. Cell Microbiol. 8 (4), 677-689 .
Paton, A.W., Beddoe, T., Thorpe, C.M., et al., 2006. AB5 subtilase cytotoxin inactivates the
endoplasmic reticulum chaperone BiP. Nature 443 (7111), 548-552 .
Paton, A.W., Paton, J.C., 2002. Direct detection and characterization of Shiga toxigenic Escherichia
coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J. Clin. Microbiol. 40 (1), 271-274 .
Paton, A.W., Srimanote, P., Talbot, U.M., et al., 2004. A new family of potent AB(5) cytotoxins
produced by Shiga toxigenic Escherichia coli . J. Exp. Med. 200 (1), 35-46 .
Paton, A.W., Srimanote, P., Woodrow, M.C., et al., 2001. Characterization of Saa, a novel auto-
agglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic
Escherichia coli strains that are virulent for humans. Infect. Immun. 69 (11), 6999-7009 .
Paton, A.W., Woodrow, M.C., Doyle, R.M., et al., 1999. Molecular characterization of a Shiga
toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of
hemolytic-uremic syndrome. J. Clin. Microbiol. 37 (10), 3357-3361 .
Paton, J.C., Paton, A.W., 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia
coli infections. Clin. Microbiol. Rev. 11 (3), 450-479 .
Parry, S.M., Salmon, R.L., 1998. Sporadic STEC O157 infection: secondary household transmission
in Wales. Emerg. Infect. Dis. 4 (4), 657-661 .
Pavia, A.T., Nichols, C.R., Green, D.P., et al., 1990. Hemolytic-uremic syndrome during an outbreak
of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical
and epidemiologic observations. J. Pediatr. 116 (4), 544-551 .
Pawar, D.M., Rossman, M.L., Chen, J., 2005. Role of curli imbriae in mediating the cells of entero-
haemorrhagic Escherichia coli to attach to abiotic surfaces. J. Appl. Microbiol. 99 (2), 418-425 .
Pearson, J.S., Riedmaier, P., Marches, O., et al., 2011. A type III effector protease NleC from
enteropathogenic Escherichia coli targets NF-kappaB for degradation. Mol. Microbiol. 80 (1),
219-230 .